CD48 Is critically involved in allergic eosinophilic airway inflammation

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 9, 2007, Pages 911-918

  Munitz, Ariel ^a   Bachelet, Ido ^a   Finkelman, Fred D ^b   Rothenberg, Marc E ^b   Levi Schaffer, Francesca ^a,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

2B4; Asthma; CD2; CD48

Indexed keywords

CD2 ANTIGEN; CD48 ANTIGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 14; OVALBUMIN; STAT PROTEIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL HYPERPLASIA; CELL SWELLING; CONTROLLED STUDY; DNA MICROARRAY; EOSINOPHIL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GOBLET CELL; LUNG; MOUSE; MUCUS SECRETION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; SENSITIZATION; SMOOTH MUSCLE; TH2 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD2; CYTOKINES; DISEASE MODELS, ANIMAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PULMONARY EOSINOPHILIA; RECEPTORS, IMMUNOLOGIC; RESPIRATORY HYPERSENSITIVITY; RNA, MESSENGER;

EID: 34247614990     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200605-695OC     Document Type: Article

References (51)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-362.
2. Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol 2005;115:953-959.
3. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol 2003;111:S799-S804.
4. Broide DH, Firestein GS. Endobronchial allergen challenge in asthma: demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J Clin Invest 1991;88:1048-1053.
5. Barnes PJ. New drugs for asthma. Nat Rev Drug Discov 2004;3:831-844.
6. Ichinose M, Barnes PJ. Cytokine-directed therapy in asthma. Curr Drug Targets Inflamm Allergy 2004;3:263-269.
7. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, Muntel EE, Witte DP, Pegg AA, Foster PS, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003;111:1863-1874.
8. Krinzman SJ, De Sanctis GT, Cernadas M, Mark D, Wang Y, Listman J, Kobzik L, Donovan C, Nassr K, Katona I, et al. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996;98:2693-2699.
9. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003;4:19-24.
10. Smith GM, Biggs J, Norris B, Anderson-Stewart P, Ward R. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J Clin Immunol 1997;17:502-509.
11. Klyushnenkova EN, Li L, Armitage RJ, Choi YS. CD48 delivers an accessory signal for CD40-mediated activation of human B cells. Cell Immunol 1996;174:90-98.
12. Yashiro-Ohtani Y, Zhou XY, Toyo-Oka K, Tai XG, Park CS, Hamaoka T, Abe R, Miyake K, Fujiwara H. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts. J Immunol 2000;164:1251-1259.
13. Killeen N, Stuart SG, Littman DR. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J 1992;11:4329-4336.
14. + T cell activation. Proc Natl Acad Sci USA 1999;96:1019-1023.
15. Barber DF, Long EO. Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol 2003;170:294-299.
16. Yokoyama S, Staunton D, Fisher R, Amiot M, Fortin JJ, Thorley-Lawson DA. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol 1991;146:2192-2200.
17. Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol 2003;170:5590-5596.
18. Shin JS, Abraham SN. Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis. FEMS Microbiol Lett 2001;197:131-138.
19. Shin JS, Gao Z, Abraham SN. Involvement of cellular caveolae in bacterial entry into mast cells. Science 2000;289:785-788.
20. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Yagita H, Bromberg JS, Vallera DA. A critical role for CD48 antigen in regulating alloengraftment and lymphohematopoietic recovery after bone marrow transplantation. Blood 1998;92:4453-4463.
21. Dreger P, Viehmann K, Loffler H, Muller-Ruchholtz W. A CD48 monoclonal antibody for reduction of graft immunogenicity. Transplant Proc 1990;22:1930.
22. Dreger P, Viehmann K, Steinmann J, Schmitz N, Suttorp M, Eckstein V, Loffler H, Muller-Ruchholtz W. CD48 monoclonal antibody K31 for bone marrow transplantation: T-depleting capacity and influence on hematopoietic progenitors. Bone Marrow Transplant 1993;12:S13-S17.
23. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med 1994;179:341-346.
24. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998;188:2083-2090.
25. + T cell proliferation by 2B4/CD48 interactions. J Immunol 2001;167:6706-6710.
26. Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, Guzior D, Latchman YE, Sayegh MH, Yagita H, Park CK, et al. Requirement of homotypic NK cell interactions through 2B4 (CD244)/CD48 in the generation of NK effector functions. Blood 2006;107:3181-3188.
27. Nakajima H, Cella M, Langen H, Friedlein A, Colonna M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 1999;29:1676-1683.
28. 2-microglobulin-free HLA-G molecules. J Immunol 2005;175:4866-4874.
29. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999;189:1565-1572.
30. Wan H, Kaestner KH, Ang SL, Ikegami M, Finkelman FD, Stahlman MT, Fulkerson PC, Rothenberg ME, Whitsett JA. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2004;131:953-964.
31. Bai Y, Fu S, Honig S, Wang Y, Qin L, Chen D, Bromberg JS. CD2 is a dominant target for allogeneic responses. Am J Transplant 2002;2:618-626.
32. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 2006;107:1996-2003.
33. Fulkerson PC, Zimmermann N, Hassman LM, Finkelman FD, Rothenberg ME. Pulmonary chemokine expression is coordinately regulated by STAT1, STAT6, and IFN-γ. J Immunol 2004;173:7565-7574.
34. Nikolaidis NM, Zimmermann N, King NE, Mishra A, Pope SM, Finkelman FD, Rothenberg ME. Trefoil factor-2 is an allergen-induced gene regulated by Th2 cytokines and STAT6 in the lung. Am J Respir Cell Mol Biol 2003;29:458-464.
35. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001;108:594-601.
36. Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, Dent LA, Young IG, Matthaei KI, Rothenberg ME, et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003;112:935-943.
37. King NE, Zimmermann N, Pope SM, Fulkerson PC, Nikolaidis NM, Mishra A, Witte DP, Rothenberg ME. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am J Respir Cell Mol Biol 2004;31:257-265.
38. Tissot C, Rebouissou C, Klein B, Mechti N. Both human α/β and γ interferons upregulate the expression of CD48 cell surface molecules. J Interferon Cytokine Res 1997;17:17-26.
39. Munitz A, Bachelet I, Eliashar R, Khoudon M, Finkelman FD, Rothenberg ME, Levi-Schaffer F. CD48 is an allergen and IL-3 induced activation molecule on eosinophils. J Immunol 2006;177:77-83.
40. Ianelli CJDR, Thorley-Lawson DA. CD48 binds to heparan sulfate on the surface of epithelial cells. J Biol Chem 1998;273:23367-23373.
41. Konishi HTH, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, Nakanishi K, et al. IL-18 contributes to the spontanous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/STAT6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 2002;99:11340-11345.
42. + T cells, IL-4 and STAT6. Nat Immunol 2000;1:132-137.
43. Fukushima K, Ikehara Y, Yamashita K. Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-γ production. J Biol Chem 2005;280:18056-18062.
44. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-588.
45. + natural killer T cells in bronchial asthma. N Engl J Med 2006;354:1117-1129.
46. + T cells upon CD226 engagement. J Immunol 2005;175:4914-4926.
47. Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol 1998;161:1962-1969.
48. Patel VP, Moran M, Low TA, Miceli MC. A molecular framework for two-step T cell signaling: Lck Src homology 3 mutations discriminate distinctly regulated lipid raft reorganization events. J Immunol 2001;166:754-764.
49. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991;254:1016-1019.
50. Abadia-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis. Gastroenterology 2006;130:424-434.
51. Mengelers HJ, Maikoe T, Brinkman L, Hooibrink B, Lammers JW, Koenderman L. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med 1994;142:345-351.